HumavantTM Human Milk Fortifier
(Human, Pasteurized)

Humavant 100% human milk-based Human Milk Fortifier
HumavantTM human milk fortifier (HMF) is the first and only commercially available human milk fortifier made from 100% human milk.
 

  • Intended for premature/low-birth-weight infants (weighing under 1250 g at birth)
  • Provides concentrated nutrition to help support the developing immune system and provide essential calories, protein, and minerals
  • Retains human milk oligosaccharide content similar to that of fresh human milk

Minimize Complications

HumavantTM HMF, when used as part of an exclusive human milk diet (EHMD), can reduce the incidence of medical complications and interventions.

Outcomes of preterm infants with medical complications

A large multicenter retrospective cohort study (1,587 patients) reported the compared outcomes of extremely premature infants (<1250 g birth weight) who received a diet including cow milk–based products vs infants who received an exclusive human milk diet. The results are consistent in both academic and real-world nonacademic settings, across multiple geographically diverse centers, and over a long period of time in a large study population.2

 
$27,388 saved in total cost of hospitalization per infant observed for VLBW babies on EHMD compared with VLBW babies on cow-milk products

Reduce Hospital Costs

Despite the added cost of donor human milk and donor milk-derived fortifier, an EHMD is cost effective.3


Learn more >>

Optimize Growth

Early and appropriate advancement of fortification is achievable with an exclusive human milk diet (EHMD) and has been associated with weight gain exceeding targeted standards.4
 

Learn more >>

Weight, length, head circumference growth velocities for infants on Prolacta
A feeding protocol for infants weighing between 500 and 1250 g that provides an EHMD with early and rapid advancement of fortification is associated with weight gain exceeding targeted standards*, with length and head circumference growth meeting targeted standards, and with a low rate of extrauterine growth restriction.4

Clinical Studies and Publications >>

 

* All costs noted are in U.S. dollars and are based on costs incurred by U.S. hospitals. Costs are for illustrative purposes only, and cost calculations will vary by hospital.
**When used as part of an EHMD. Outcome measures were statistically based on mean weight data.
NOTE: Product used in these studies was named Prolact+ H2MF®. The formulation of Prolact H2MF® and HumavantTM HMF is the same. Prolact+ H2MF® is the trade name in North America and HumavantTM HMF is the trade name outside North America.

  1. Data on file.
  2. Hair AB, Peluso AM, Hawthorne KM, et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk–based diet. Breastfeed Med. 2016;11(2):70-74.
  3. Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220.
  4. Hair AB, Hawthorne KM, Chetta KE, Abrams SA. Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Res Notes. 2013;6:459.